Piramal Pharma Limited (PPLPHARMA) — Free Cash Flow Generation Index
Piramal Pharma Limited (PPLPHARMA) has a Free Cash Flow Generation Index of 0.51x as of September 2025. Free cash flow of Rs4.57 Billion represents 1% of operating cash flow (Rs8.90 Billion). Explore Piramal Pharma Limited capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Piramal Pharma Limited Free Cash Flow Generation Index (2021–2026)
Historical FCF Generation Index trend for Piramal Pharma Limited across 6 annual periods. For the full cash flow conversion analysis, see PPLPHARMA cash generation efficiency.
Annual Free Cash Flow Generation for Piramal Pharma Limited (2021–2026)
Year-by-year Free Cash Flow Generation Index for Piramal Pharma Limited. Check PPLPHARMA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.36x | Rs5.10 Billion | Rs14.00 Billion | Rs8.90 Billion | ▲ +42.5% |
| 2025 | 0.26x | Rs2.28 Billion | Rs8.92 Billion | Rs6.64 Billion | ▼ -12.3% |
| 2024 | 0.29x | Rs2.92 Billion | Rs10.05 Billion | Rs7.12 Billion | ▲ +129.3% |
| 2023 | -0.99x | Rs-4.81 Billion | Rs4.84 Billion | Rs9.65 Billion | ▼ -563.7% |
| 2022 | 0.21x | Rs546.90 Million | Rs2.55 Billion | Rs2.01 Billion | ▲ +131.8% |
| 2021 | -0.67x | Rs-233.90 Million | Rs347.20 Million | Rs581.10 Million | — |